Pietro Lampertico
Department of Pathophysiology and Transplantation, University of Milan
It is with profound sadness that we announce the passing of Jack R. Wands, MD, FAASLD, 80, Chief of the Division of Gastroenterology at the Warren Alpert Medical School of Brown University and Rhode Island Hospital/Lifespan. Jack was a leader in the field of Hepatology and among the most prolific investigators in the history of the medical school. His dominant scholarly accomplishments included improving our understanding of the molecular pathogenesis of chronic Hepatitis B and C, and dissecting pivotal intracellular signaling networks that govern the progression of alcohol-related liver disease to either cirrhosis or liver cancer. Those efforts led to pioneering research and the discovery of tumor-associated molecules that drive the invasive and metastatic spread of liver cancer cells. Importantly, the lessons learned were found highly relevant to many other malignancies, holding promise for novel diagnostic and therapeutic strategies for tumors that still lack effective treatment. Throughout his career, Jack was passionate about translating his important laboratory research discoveries to advance liver cancer diagnostics and therapeutics in human patients. In conjunction with his scholarly activities, Jack was a superb mentor who had an impressive impact on the successes and career trajectories of countless trainees. These ranged from undergraduate, graduate, and medical students to postdoctoral fellows and junior to mid-career faculty on virtually every continent. He is survived by his children, Greg and Raymie and his grandchildren Robby and Amanda.
Department of Pathophysiology and Transplantation, University of Milan
University of Iowa Hospitals and Clinics
Ege University Faculty of Medicine
Join us for a compelling community conversation where we explore the vital role of patient-led advocacy in healthcare. Discover how the Global Liver Institute empowers patients to make a lasting impact on liver health and beyond. Learn from real-world exp
Join us for an enlightening Community Conversation as we discuss why doctors and experts are moving away from terms like NAFLD and NASH, and using new terms such as SLD, MASLD, MASH, and MetALD. This is not just a name change; it is a transformative appro
Navigating your health care journey can be challenging. This program will empower you to actively participate in your medical care and provide you with the tools to not only be a patient or caregiver, but a partner with your health care team in your journ
Health disparities in the U.S. became more apparent during the pandemic. The Community Liver Alliance Addressing Disparities in Liver Disease Conference took place on April 16, 2023. This convening empowered us to address health disparities, including d
With 7,000 known rare diseases, how do you get attention for your rare liver disease? With more awareness and understanding of your disease, both the general public and physicians will think of it and hopefully consider it for diagnosis. With greater know